Literature DB >> 12054860

Alternate usage of two dimerization initiation sites in HIV-2 viral RNA in vitro.

Jean-Marc Lanchy1, J Stephen Lodmell.   

Abstract

An essential step in the replication cycle of all retroviruses is the dimerization of genomic RNA prior to or during encapsidation and budding. In HIV-1, a stem-loop structure in the genomic RNA called the dimerization initiation site, or DIS, has been well characterized. However, the identification of the structure(s) necessary for dimerization of HIV-2 genomic RNA has been less straightforward, as reflected by recent conflicting reports. Here, using a variety of mutant and wild-type RNA constructs and a systematic analysis of experimental conditions, we demonstrate that two dimerization sites in HIV-2 RNA are clearly discernible under different experimental conditions. A short sequence overlapping the primer binding site acts as the default dimerization site for wild-type viral RNA transcripts of several lengths provided that dimerization incubation conditions do not include a high heat step (>50 degrees C), and electrophoresis is carried out under mild conditions that do not deplete the RNA of magnesium. However, some RNA constructs are able to dimerize through stem-loop 1 (SL1), which is the structure homologous to the HIV-1 DIS, under certain experimental conditions. Interestingly, deletion or mutation of the default PBS dimerization site leads to efficient usage of the SL1 dimerization site. This study defines conditions under which each site may be used for dimerization and demonstrates, furthermore, the facility with which the two sites can substitute for each other. This is suggestive of a switching mechanism that may be used in the viral replication cycle. (c) 2002 Elsevier Science Ltd.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12054860     DOI: 10.1016/S0022-2836(02)00369-8

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  19 in total

1.  Elements located upstream and downstream of the major splice donor site influence the ability of HIV-2 leader RNA to dimerize in vitro.

Authors:  Jean-Marc Lanchy; Casey A Rentz; John D Ivanovitch; J Stephen Lodmell
Journal:  Biochemistry       Date:  2003-03-11       Impact factor: 3.162

2.  A structural linkage between the dimerization and encapsidation signals in HIV-2 leader RNA.

Authors:  Jean-Marc Lanchy; John D Ivanovitch; J Stephen Lodmell
Journal:  RNA       Date:  2003-08       Impact factor: 4.942

3.  Splicing affects presentation of RNA dimerization signals in HIV-2 in vitro.

Authors:  Jean-Marc Lanchy; Quenna N Szafran; J Stephen Lodmell
Journal:  Nucleic Acids Res       Date:  2004-08-27       Impact factor: 16.971

4.  Identification and characterization of critical cis-acting sequences within the yeast Ty1 retrotransposon.

Authors:  Eric C Bolton; Candice Coombes; Yolanda Eby; Mattias Cardell; Jef D Boeke
Journal:  RNA       Date:  2005-01-20       Impact factor: 4.942

5.  HIV-2 RNA dimerization is regulated by intramolecular interactions in vitro.

Authors:  Tayyba T Baig; Jean-Marc Lanchy; J Stephen Lodmell
Journal:  RNA       Date:  2007-06-25       Impact factor: 4.942

6.  Mechanisms of human immunodeficiency virus type 2 RNA packaging: efficient trans packaging and selection of RNA copackaging partners.

Authors:  Na Ni; Olga A Nikolaitchik; Kari A Dilley; Jianbo Chen; Andrea Galli; William Fu; V V S P Prasad; Roger G Ptak; Vinay K Pathak; Wei-Shau Hu
Journal:  J Virol       Date:  2011-05-25       Impact factor: 5.103

7.  HIV-2 genome dimerization is required for the correct processing of Gag: a second-site reversion in matrix can restore both processes in dimerization-impaired mutant viruses.

Authors:  Anne L'Hernault; Eva U Weiss; Jane S Greatorex; Andrew M Lever
Journal:  J Virol       Date:  2012-03-14       Impact factor: 5.103

8.  Functional analysis of the complex trans-activating response element RNA structure in simian immunodeficiency virus.

Authors:  Mireille Centlivre; Bep Klaver; Ben Berkhout; Atze T Das
Journal:  J Virol       Date:  2008-07-02       Impact factor: 5.103

9.  Elucidation and characterization of oligonucleotide-accessible sites on HIV-2 leader region RNA.

Authors:  Emily L Deer; Boramee Douk; Jean-Marc Lanchy; J Stephen Lodmell
Journal:  Antisense Nucleic Acid Drug Dev       Date:  2003-02

10.  A riboswitch regulates RNA dimerization and packaging in human immunodeficiency virus type 1 virions.

Authors:  Marcel Ooms; Hendrik Huthoff; Rodney Russell; Chen Liang; Ben Berkhout
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.